Arca Biopharma Inc (ABIO) - News Archive

The Combined Future: Arca Biopharma Inc. Merges with Oruka Therapeutics, Inc. and Takes the Nasdaq by StormIn a significant move poised to reshape the landscape of precision medicine for cardiovascular diseases, Arca Bi...

ARCA Biopharma s Special Dividend Amid Merger Talks: What Investors Need to KnowOn August 26, 2024, ARCA biopharma, Inc. (NASDAQ: ABIO) released a press statement announcing a special dividend of $1.613 per share of com...

ARCA biopharma Inc, a leader in In Vitro & In Vivo Diagnostic Substances, recently announced their financial results for the first quarter of 2024. The company reported a market capitalization of $42 million, showcasing...

The recent merger agreement between ARCA biopharma and Oruka Therapeutics has paved the way for a new era in the treatment of chronic skin diseases. This anticipated merger aims to harness Oruka s innovative portfolio o...